Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Covidien plc    COV   IE00B68SQD29

COVIDIEN PLC (COV)

21
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/20/2014 10/21/2014 10/22/2014 10/23/2014 10/24/2014 Date
85.44(c) 89.25(c) 87.41(c) 88.45(c) 89.05 Last
9 822 557 8 814 227 4 433 853 2 034 427 388 041 Volume
+3.94% +4.46% -2.06% +1.19% +0.68% Change
More quotes
Company
Covidien Plc engages in the development, manufacture and sale of healthcare products for use in clinical and home settings.It operates through three segments: Medical Devices, Pharmaceuticals and Medical Supplies.The Medical Devices segment includes the development, manufacture and sale of... 
Surperformance© rating of Covidien plc
Trading Rating : Investor Rating :
More about the company
Chart COVIDIEN PLC
Duration : Period :
Covidien plc Technical Analysis Chart | COV | IE00B68SQD29 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 10 612 M
EBIT 2014 2 376 M
Net income 2014 1 642 M
Debt 2014 3 201 M
Yield 2014 1,47%
Sales 2015 11 066 M
EBIT 2015 2 548 M
Net income 2015 1 968 M
Debt 2015 2 094 M
Yield 2015 1,59%
PER 2014 24,63
PER 2015 20,16
EV / Sales 2014 4,07x
EV / Sales 2015 3,80x
Capitalization 39 958 M
More Financials
Latest news on COVIDIEN PLC
1d ago COVIDIEN : Joins Forces with the American Lung Association to Help Women Underst..
2d ago COVIDIEN : 93% of U.S., 92% of New Yorkers Unaware that Stroke is Second Leading..
10/17DJU.S. HOT STOCKS : Hot Stocks to Watch
10/17 COVIDIEN : U.S. District Court Grants Covidien Preliminary Injunction against Et..
10/15DJMARKET SNAPSHOT : U.S. Stocks Cut Losses In Harrowing, Volatile Session
10/15DJMARKET SNAPSHOT : U.S. Stocks Plummet As Selling Intensifies
10/13 Medtronic seeks EU approval for $43 billion Covidien deal
10/10 COVIDIEN : Initiates Voluntary Field Safety Alert for Medi-Trace™ Cadence ..
10/10DJU.S. HOT STOCKS : Hot Stocks to Watch
10/10 COVIDIEN : Announcement under Irish Takeover Rules Relevant Securities in Issue ..
10/09 COVIDIEN : Announces U.S. Food and Drug Administration 510(k) Clearance for Nell..
10/08 COVIDIEN : Form 8.1 – Covidien
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF